Table 7.60Function in hip OA

Function outcomeReferenceInterventionAssessment timeOutcome/effect size
OARSI outcome measures1 RCT (Qvistgaard et al. 2006) (N=104)Methylprednisolone vs placeboDay 14 and day 28 (end of treatment)Day 14: 56% (CS) and 33% (placebo)
Day 28: 66% (CS) and 44% (placebo)

From: 7, Pharmacological management of osteoarthritis

Cover of Osteoarthritis
Osteoarthritis: National Clinical Guideline for Care and Management in Adults.
NICE Clinical Guidelines, No. 59.
National Collaborating Centre for Chronic Conditions (UK).
Copyright © 2008, Royal College of Physicians of London.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.